Sodium pump inhibition by sulfhydryl inhibitors and myocardial contractility.
D000818:Animals; D001693:Biological Transport, Active / Q000187:drug effects; D002729:Chloromercuribenzoates / Q000494:pharmacology; D003864:Depression, Chemical; D005033:Ethylmaleimide / Q000494:pharmacology; D005260:Female; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism*; D012413:Rubidium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism*; D013439:Sulfhydryl Reagents / Q000494:pharmacology*; D013997:Time Factors
D002729:Chloromercuribenzoates; D013439:Sulfhydryl Reagents; D012964:Sodium; D012413:Rubidium; D005033:Ethylmaleimide